Literature DB >> 7982482

Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue SMS 201-995.

Y Fujii1, T Gonoi, Y Yamada, K Chihara, N Inagaki, S Seino.   

Abstract

Somatostatin and its analogue SMS 201-995 inhibit high voltage-activated (HVA) Ca2+ currents in the rat insulinoma cell line RINm5F which stably express cloned human somatostatin receptor subtype 2 (hSSTR2). In contrast, neither somatostatin nor SMS 201-995 suppresses the HVA Ca2+ currents in RINm5F which stably express cloned hSSTR1. These results suggest that somatostatin-induced inhibition of HVA Ca2+ currents is mediated by a specific receptor subtype and that inhibition of calcium influx through HVA Ca2+ channels is one of the mechanisms of SMS 201-995 action on inhibitory processes of hormone secretion and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982482     DOI: 10.1016/0014-5793(94)01159-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Selective G-protein regulation of neuronal calcium channels.

Authors:  P T Toth; L R Shekter; G H Ma; L H Philipson; R J Miller
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

Review 2.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

3.  Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout.

Authors:  Michael Norman; Stefan Moldovan; Victor Seghers; Xiao-Ping Wang; Francesco J DeMayo; F Charles Brunicardi
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

4.  Research Resource: Real-Time Analysis of Somatostatin and Dopamine Receptor Signaling in Pituitary Cells Using a Fluorescence-Based Membrane Potential Assay.

Authors:  Thomas Günther; Michael Culler; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2016-03-11

5.  Somatostatin-Mediated Changes in Microtubule-Associated Proteins and Retinoic Acid-Induced Neurite Outgrowth in SH-SY5Y Cells.

Authors:  Seungil Paik; Rishi K Somvanshi; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2019-03-16       Impact factor: 3.444

6.  Comparative distribution of somatostatin and somatostatin receptors in PTU-induced hypothyroidism.

Authors:  Sneha Singh; Rishi K Somvanshi; Vandana Panda; Ujendra Kumar
Journal:  Endocrine       Date:  2020-04-25       Impact factor: 3.633

7.  Primate cell fusion disentangles gene regulatory divergence in neurodevelopment.

Authors:  Sergiu P Pașca; Hunter B Fraser; Rachel M Agoglia; Danqiong Sun; Fikri Birey; Se-Jin Yoon; Yuki Miura; Karen Sabatini
Journal:  Nature       Date:  2021-03-17       Impact factor: 49.962

Review 8.  Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.

Authors:  Mehtap Cakir; Dorota Dworakowska; Ashley Grossman
Journal:  J Cell Mol Med       Date:  2010-11       Impact factor: 5.310

9.  Peptide receptor targeting in cancer: the somatostatin paradigm.

Authors:  Federica Barbieri; Adriana Bajetto; Alessandra Pattarozzi; Monica Gatti; Roberto Würth; Stefano Thellung; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Tullio Florio
Journal:  Int J Pept       Date:  2013-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.